SCHEMBL7216359

SCHEMBL7216359

O=C(O)C1=Cc2cc(OCc3ccccc3)ccc2CCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.56
RAB9A P51151 6/20 0.56
RXRB P28702 4/20 0.56
RXRA P19793 3/20 0.56
RXRG P48443 3/20 0.56
MAOA P21397 3/20 0.56
MAOB P27338 3/20 0.56
POLB P06746 1/20 0.56
GFER P55789 1/20 0.56
PAX8 Q06710 1/20 0.56
KLF5 Q13887 1/20 0.56
MRGPRX4 Q96LA9 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
SMN1; SMN2 Q16637 4/20 0.49
KDM4E B2RXH2 1/20 0.49
ALOX5 P09917 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7222385 0.93 NPC1 (0.55) NPC1RAB9ARXRBRXRARXRG
SCHEMBL7218008 0.90 RXRB (0.57) NPC1RAB9ARXRBRXRARXRG
SCHEMBL7222242 0.89 MAOB (0.57) NPC1RAB9ARXRBRXRARXRG
SCHEMBL7222844 0.88 MAPT (0.53) NPC1RAB9ARXRBRXRARXRG
SCHEMBL7222036 0.88 NPC1 (0.55) NPC1RAB9ARXRBRXRARXRG
SCHEMBL7216468 0.84 RXRB (0.47) NPC1RAB9ARXRBRXRARXRG
SCHEMBL9620847 0.84 RXRB (0.47) NPC1RAB9ARXRBRXRARXRG
SCHEMBL7216413 0.83 NPC1 (0.46) NPC1RAB9ARXRBRXRARXRG
SCHEMBL7222970 0.82 MAPT (0.52) NPC1RAB9ARXRBRXRARXRG
SCHEMBL8064409 0.82 MAOB (0.51) NPC1RAB9ARXRBRXRARXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed